Company intelligence / Profile preview

Actylis

Port Washington, New York, United Statesactylis.com ↗

Ownership: Private
Development stage: Commercial

Overview

Actylis operates globally as a leading manufacturer and distributor of critical raw materials and performance ingredients for the life sciences industry. It provides GMP custom manufacturing services for APIs, intermediates, excipients, cell culture media components, buffers/process solutions—serving both clinical development and commercial production. The company’s facilities are routinely audited by regulatory bodies to ensure high quality standards. No clinical results apply as it does not sponsor drug trials.

Modalities: Small moleculeBiologicExcipientsWater for InjectionBuffers and process solutions
Industry: Contract Manufacturing Organization

Partnerships

Strategic supplier partnerships in the pharmaceutical/nutritional ingredient space; specific partners not named in public sources.

Beyond the preview

Go deeper on Actylis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actylis.

Explore the full profile